Anxiety, Depression, Drowsiness and Insomnia in Cancer Patients

Nasrin Taghizadeh^*
*Correspondence: Nasrin Taghizadeh, Department of Nursing, School of Health and Welfare, Jonkoping University, Jonkoping, Sweden, Email:

Description

One of the most devastating non-communicable diseases (NCDs), malignant growth impacts individuals as well as their close relatives and companions in various ways. Around 10 million people will die from malignant growth in 2020, and there will be 19.3 million new cases overall. The patient may face extensive psychosocial difficulties as a result of the high mortality rate, complicated medical procedures, and financial burden. Hence, problems with emotional well-being are common in malignant growth. For instance, the malignant growth analysis itself may disturb the patient, especially if it is presented to them ineffectively and without the proper guidance. In any case, for individuals without a history of dysfunctional behaviour, this may have a significant impact on their psychological health, personal pleasure, and prosperity [1].

There is solid evidence that all cancer patients run the risk of developing psychological maladjustment. Malignant growth patients have been discovered to have a few psychological disorders, such as depression and stress. In addition, there are generally significant regions of strength between various psychiatric illnesses. There have been significant correlations between emotional well-being traits including stress, discouragement, sluggishness, a sleeping issue, and rest quality in patients with malignant growth. The efficacy of managing malignant development is further complicated by these psychological maladjustments, which further perplex therapeutic techniques. Clinicians should use a framework that checks patients' psychological wellbeing levels in order to benefit from brief intercession that will also increase their prosperity and sense of fulfilment (QoL) [2].

A key aspect and focus of the entire course of treatment is the health and quality of life of patients with illness. Every hope of enduring via the will and therapy is fueled by the possibility of recovering one's health. Malignant growth negatively affects patients' QoL (counting detection and treatment). Moreover, psychological maladjustment has a big influence on patients' quality of life since QoL reflects how a disease impacts a person's everyday life. Moreover, there has been evidence of a significant link between QoL and dysfunctional behaviours, such as stress, misery, sleepiness, a sleeping problem, and rest quality [3]. This demonstrates that illnesses have a higher likelihood of affecting quality of life.

Due to patients' increased use of web-based entertainment as a form of communication or maybe as a source of information, the present Covid 2019 (COVID-19) pandemic situation is aggravating the usually crucial medical care demands of patients with malignant development. This is particularly true as a result of the preventive measures put in place to halt the development of COVID-19. Naturally, the use of physical separation, lockdowns, and isolation restricts patients' access to high-quality medical care. These COVID-19 prevention measures also restrict social support, especially from family and friends [4].

The findings indicated that there were strong relationships among the variables, but the intervention analysis revealed that the usage of difficult virtual entertainment had no direct effect on patients' quality of life (QoL) save via unease, gloom, fatigue, and sleep deprivation. This implies that healthcare workers should concentrate on how patients use electronic devices, the internet, and virtual entertainment to properly educate them about the effects of such a habit on their mental wellbeing and QoL [5]. Future studies may examine a variety of disease-related QoL-influencing variables as well as other mediating and directing factors.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Sung, Hyuna, Jacques Ferlay, Rebecca L. Siegel and Mathieu Laversanne, et al. “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.” CA Cancer J Clin 71 (2021): 209–249.

Google Scholar, Crossref, Indexed at

2. Bray, Freddie, Mathieu Laversanne, Elisabete Weiderpass and Isabelle Soerjomataram. “The ever-increasing importance of cancer as a leading cause of premature death worldwide.” Cancer 127 (2021): 3029–3030.

Google Scholar, Crossref, Indexed at

3. Niedzwiedz, Claire L., Lee Knifton, Kathryn A. Robb and Srinivasa Vittal Katikireddi, et al. “Depression and anxiety among people living with and beyond cancer: A growing clinical and research priority.” BMC Cancer 19 (2019): 943.

Google Scholar, Crossref, Indexed at

4. Ugalde, Anna, Kerry Haynes, Anna Boltong and Victoria White, et al. “Self-guided interventions for managing psychological distress in people with cancer-A systematic review.” Patient Educ Couns 100 (2017): 846–857.

Google Scholar, Crossref, Indexed at

5. Wang, Yuanyuan, Zhizhou Duan, Zikun Ma and Yize Mao, et al. “Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic.” Transl Psychiatry 10 (2020): 263.

Google Scholar, Crossref, Indexed at